Semaglutide
GLP-1 receptor agonist research peptide, the most-studied compound in the incretin class. Lyophilized powder, batch-tested by HPLC.
Lot SG-2601 tested at 98.50% by HPLC (RP-HPLC / HPLC-RTM). Certificate COA-2026-9433, issued 2026-07-02 by Titreon Analytical.
Read the certificateDownload the PDFWhat Semaglutide is
Semaglutide is a GLP-1 receptor agonist and the most extensively published compound in the incretin class. The literature describes slowed gastric emptying, glucose-dependent insulin release and central appetite signalling. Supplied as a lyophilized powder for laboratory and in-vitro research use.
Specifications
- CAS
- 910463-68-2
- Formula
- C₁₈₇H₂₉₁N₄₅O₅₉
- MW
- 4113.58 g/mol
Laboratory research use only. Not for human or animal consumption. This product is supplied as a chemical reference compound for controlled in-vitro and laboratory research. It is not a drug, food, cosmetic or medical device, and it has not been evaluated by the FDA for safety or efficacy.
Product information is published for educational and documentation purposes. It describes what the compound is and what published research reports. It is not medical advice, not a recommendation that any person use any compound, and not instructions for use in humans. See the full research disclaimer.